Comparative effectiveness of bevacizumab, cetuximab, and panitumumab for improving outcomes in metastatic colorectal cancer: a propensity overlap weighting analysis
Cetuximab and panitumumab were more effective than bevacizumab at improving survival outcomes and facilitating conversion surgery in left-sided mCRC. These findings highlight the importance of tumor laterality and molecular profiling in guiding therapeutic strategies.
Authors
- Pei‐Ting Lee (ORCID: https://orcid.org/0009-0005-5213-1218)
- Chien‐Chou Su (ORCID: https://orcid.org/0000-0001-5046-125X)
- Yi‐Chia Su (ORCID: https://orcid.org/0000-0002-9544-1153)
- Chih‐Chien Wu (ORCID: https://orcid.org/0000-0001-5791-4047)
Institutions
- National Yang Ming Chiao Tung University (TW)
- Kaohsiung Medical University (TW)
- Min-Hwei College of Health Care Management (TW)
- Kaohsiung Veterans General Hospital (TW)
- National Cheng Kung University Hospital (TW)
- National Cheng Kung University (TW)
Publication Details
- Journal
- Annals of Coloproctology
- Published
- 2025-10-27
- DOI
- https://doi.org/10.3393/ac.2025.00059.0008
- Citations
- 2
- Primary Topic
- Colorectal Cancer Treatments and Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.09